336 related articles for article (PubMed ID: 19284078)
21. Analysis of left main coronary artery bifurcation lesions treated with biolimus-eluting DEVAX AXXESS plus nitinol self-expanding stent: intravascular ultrasound results of the AXXENT trial.
Hasegawa T; Ako J; Koo BK; Miyazawa A; Sakurai R; Chang H; Dens J; Verheye S; Grube E; Honda Y; Fitzgerald PJ
Catheter Cardiovasc Interv; 2009 Jan; 73(1):34-41. PubMed ID: 19089934
[TBL] [Abstract][Full Text] [Related]
22. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
[TBL] [Abstract][Full Text] [Related]
23. Nobori stent shows less vascular inflammation and early recovery of endothelial function compared with Cypher stent.
Pendyala LK; Matsumoto D; Shinke T; Iwasaki T; Sugimoto R; Hou D; Chen JP; Singh J; King SB; Chronos N; Li J
JACC Cardiovasc Interv; 2012 Apr; 5(4):436-44. PubMed ID: 22516402
[TBL] [Abstract][Full Text] [Related]
24. Endothelial function rather than endothelial restoration is altered in paclitaxel- as compared to bare metal-, sirolimusand tacrolimus-eluting stents.
van Beusekom HM; Sorop O; van den Heuvel M; Onuma Y; Duncker DJ; Danser AH; van der Giessen WJ
EuroIntervention; 2010 May; 6(1):117-25. PubMed ID: 20542807
[TBL] [Abstract][Full Text] [Related]
25. Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial.
Di Lorenzo E; Sauro R; Varricchio A; Carbone G; Cortese G; Capasso M; Lanzillo T; Manganelli F; Mariello C; Siano F; Pagliuca MR; Stanco G; Rosato G; De Luca G
Circulation; 2009 Sep; 120(11):964-72. PubMed ID: 19720939
[TBL] [Abstract][Full Text] [Related]
26. Abnormal vasomotor function of porcine coronary arteries distal to sirolimus-eluting stents.
Li J; Jabara R; Pendyala L; Otsuka Y; Shinke T; Hou D; Robinson K; Chronos N
JACC Cardiovasc Interv; 2008 Jun; 1(3):279-85. PubMed ID: 19463313
[TBL] [Abstract][Full Text] [Related]
27. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
[TBL] [Abstract][Full Text] [Related]
28. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents.
Finn AV; Kolodgie FD; Harnek J; Guerrero LJ; Acampado E; Tefera K; Skorija K; Weber DK; Gold HK; Virmani R
Circulation; 2005 Jul; 112(2):270-8. PubMed ID: 15998681
[TBL] [Abstract][Full Text] [Related]
29. The significance of preclinical evaluation of sirolimus-, paclitaxel-, and zotarolimus-eluting stents.
Nakazawa G; Finn AV; John MC; Kolodgie FD; Virmani R
Am J Cardiol; 2007 Oct; 100(8B):36M-44M. PubMed ID: 17950831
[TBL] [Abstract][Full Text] [Related]
30. Intravascular ultrasound analysis of small vessel lesions treated with the Sparrow coronary stent system: results of the CARE II trial.
Kume T; Waseda K; Koo BK; Yock PG; Botelho R; Verheye S; Whitbourn R; Meredith I; Worthley S; Hai KT; Honda Y; Abizaid A; Fitzgerald PJ
Catheter Cardiovasc Interv; 2014 Jan; 83(1):19-24. PubMed ID: 23413202
[TBL] [Abstract][Full Text] [Related]
31. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
[TBL] [Abstract][Full Text] [Related]
32. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
[TBL] [Abstract][Full Text] [Related]
33. Lowering the dose of sirolimus, released from a nonpolymeric hydroxyapatite coated coronary stent, reduces signs of delayed healing.
van der Giessen WJ; Sorop O; Serruys PW; Peters-Krabbendam I; van Beusekom HM
JACC Cardiovasc Interv; 2009 Apr; 2(4):284-90. PubMed ID: 19463438
[TBL] [Abstract][Full Text] [Related]
34. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
35. Assessment of potential relationship between wall shear stress and arterial wall response after bare metal stent and sirolimus-eluting stent implantation in patients with diabetes mellitus.
Suzuki N; Nanda H; Angiolillo DJ; Bezerra H; Sabaté M; Jiménez-Quevedo P; Alfonso F; Macaya C; Bass TA; Ilegbusi OJ; Costa MA
Int J Cardiovasc Imaging; 2008 Apr; 24(4):357-64. PubMed ID: 17972162
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
[TBL] [Abstract][Full Text] [Related]
37. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
38. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
39. The union of anti-CD34 antibody can improve the performance of drug-eluting stents.
Yang XS; Zhu HG; Yu ZJ; Ren F; Chen YQ; Wu X; Zhang ZC; Zhang LJ; Lu SZ
Catheter Cardiovasc Interv; 2012 May; 79(6):972-8. PubMed ID: 22162277
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
